Resultados de la búsqueda 531-540 of 12265 for 搜索引擎优化关键字咨询邮箱：lgooxc@hotmail.com

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objectives of this study are to determine if a tailored prehabilitation program focusing on functional optimization of spared limb tissue in two ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to evaluate the safety and effectiveness of MK-1026 (formerly ARQ 531) in participants with hematologic ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  6. Ahogamiento: primeros auxilios - Mayo Clinic

    Prepárate para proporcionar primeros auxilios de emergencia si tú u otra persona se están atragantando.

  7. Hematología - Ensayos clínicos - Mayo Clinic

    99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...